Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Cancer. 2015 Aug 4;121(21):3836–3843. doi: 10.1002/cncr.29590

Table 1.

Patient and Tumor Characteristics

N=270 %
Gender Male 127 47
Female 143 53

Primary Cancer Non-small cell lung cancer 99 36.7
Breast cancer 63 23.3
Melanoma 56 20.7
Other 52 19.3

ECOG PS 0 137 50.9
1 109 40.5
2 or 3 23 8.6
Missing 1 -

Active Systemic Disease No 140 52
Yes 129 48
Missing 1 -

Extracranial Metastatic Sites No 133 49.4
Yes 136 50.6
Missing 1 -

Previous WBRT No 185 68.5
Yes 85 31.5

CTX During SRS (<30 Days) No 213 79.2
Yes 56 20.8
Missing 1 -

Intact and Resected Metastases Intact 406 85.5
Resected 86 14.5

Number of Metastases Treated at First Session 1 160 59.3
2 61 22.6
≥3 49 18.1
Median if ≥3 (Range) 4 (3-7)

Age (years) 18-44 53 19.6
45-54 68 25.2
55-59 48 17.8
≥60 101 37.4
Median (Range) 56 (18-87) -

Total Volume from First Session (cm^3) 0-<0.3 45 17.6
0.3-<1.3 56 21.9
1.3-<3.3 54 21.1
3.3-<7.6 50 19.5
≥7.6 51 19.9
Mean (SD) 4.02 (4.76)
Median (Range) 2.21 (0.032-22.3)

Number of Metastases Treated at First Session Mean (SD) 1.78 (1.27)
Median (Range) 1 (1-7)

PS = Performance Status, WBRT = Whole Brain Radiation Therapy, CTX = Chemotherapy, SRS = Stereotactic Radiosurgery, SD = Standard Deviation